The authors conducted a double-blind, randomized, placebo-controlled trial to ascertain whether the use of fluconazole prophylaxis in 125 high-risk, critically ill patients would decrease the incidence of severe candida infection. Secondary objectives included assessing the impact of prophylaxis on ...
No comments yet
Be the first to share your thoughts!